![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 47/50 | (2017.01) |
A61K 47/60 | (2017.01) | ||
A61K 38/29 | (2006.01) | ||
A61P 5/00 | (2006.01) | ||
A61P 5/18 | (2006.01) | ||
A61P 7/00 | (2006.01) | ||
A61P 7/08 | (2006.01) | ||
A61P 19/00 | (2006.01) | ||
A61P 19/02 | (2006.01) | ||
A61P 19/08 | (2006.01) | ||
A61P 19/10 | (2006.01) | ||
A61P 43/00 | (2006.01) |
(11) | Number of the document | 3518982 |
(13) | Kind of document | T |
(96) | European patent application number | 17781426.6 |
Date of filing the European patent application | 2017-09-28 | |
(97) | Date of publication of the European application | 2019-08-07 |
(45) | Date of publication and mention of the grant of the patent | 2024-11-27 |
(46) | Date of publication of the claims translation | 2025-02-25 |
(86) | Number | PCT/EP2017/074593 |
Date | 2017-09-28 |
(87) | Number | WO 2018/060311 |
Date | 2018-04-05 |
(30) | Number | Date | Country code |
16191453 | 2016-09-29 | EP |
(72) |
KARPF, David Brian , US
SPROGØE, Kennett , DK
HOLTEN-ANDERSEN, Lars , DK
|
(73) |
Ascendis Pharma Bone Diseases A/S ,
Tuborg Boulevard 12, 2900 Hellerup,
DK
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Kontroliuojamo atpalaidavimo PTH junginiai |
CONTROLLED-RELEASE PTH COMPOUNDS |